fluconazole and warfarin

fluconazole has been researched along with warfarin in 49 studies

Research

Studies (49)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (2.04)	18.7374
1990's	11 (22.45)	18.2507
2000's	10 (20.41)	29.6817
2010's	24 (48.98)	24.3611
2020's	3 (6.12)	2.80

Authors

Authors	Studies
Duffy, EM; Jorgensen, WL	1
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Aguilera-Venegas, B; Bloomer, WD; Chatelain, E; Ioset, JR; Kaiser, M; Lepesheva, GI; Papadopoulou, MV; Rosenzweig, HS; Wilkinson, SR	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Carey, D; Lee, HS; Tett, S	1
Gibaldi, M	1
Black, DJ; Celum, CL; Seaton, TL	1
Rieth, H; Sauerbrey, N	1
Baciewicz, AM; Baud, EB; Bokar, JA; Menke, JJ	1
Crussell-Porter, LL; Ford, MA; Jaskar, DW; Rindone, JP	1
Kerr, HD	1
Kunze, KL; Rettie, AE; Storch, E; Trager, WF; Wienkers, LC; Wurden, CJ	1
Kunze, KL; Thummel, KE; Trager, WF; Wienkers, LC	1
Bauwens, JE; Black, DJ; Evans, JS; Gidal, BE; Kunze, KL; McDonnell, ND; Seaton, TL; Trager, WF; Wienkers, LC	1
Kunze, KL; Trager, WF	1
Ariyaratnam, S; Pemberton, M; Sloan, P; Thakker, NS; Thornhill, MH	1
Das, A; Mootha, VV; Schluter, ML	1
Allison, EJ; Langenberg, JN; McKinney, TJ	1
Kunze, KL; Levy, RH; Neal, JM; O'Reilly, RA; Trager, WF	1
Turrentine, MA	1
Ditmer, D; Feldstein, AC; Krall, M; Perrin, N; Platt, R; Simon, SR; Sittig, DF; Smith, DH; Soumerai, SB; Yang, X	1
Bergman, U; Bertilsson, L; Engström Hellgren, K; Helldén, A; Masquelier, M; Nilsson Remahl, I; Odar-Cederlöf, I; Ramsjö, M	1
Bavisotto, LM; Canafax, DM; Combs, DL; Ellis, DJ; Irwin, I; Milner, PG	1
Geng, RX; Ji, QG; Shi, Y; Zhou, CH; Zhou, XD	1
Al-Ayed, AS; Hamdi, N	1
Fukatsu, S; Habu, Y; Kimura, Y; Matsubara, K; Ozaki, J; Sato, E; Shida, A; Yamamoto, H; Yano, I	1
Hersh, EV; Moore, PA	1
Akiyoshi, T; Hakoda, R; Imaoka, A; Ohtani, H	1
Cagnoli, GA; Cassina, M; Clementi, M; Di Gianantonio, E; Zuccarello, D	1
Chai, D; Du, J; Guan, SX; Huang, XW; Jiang, YY; Li, DD; Sun, Y; Zhang, HY	1
Cao, YB; Gu, LQ; Han, B; Jiang, YY; Li, LP; Shen, CY; Wang, XJ; Yang, QL; Yu, YQ; Zhang, JY; Zhang, LL	1
de Abajo, FJ; Gaist, D; Martín-Pérez, M; Rodríguez, LAG	1
de Filette, J; Michiels, V	1
Brüggemann, R; Wasmann, R	1
Aabenhus, RM; Hellfritzsch, M; Iversen, DB; Lind, BS; Pottegård, A; Stage, TB	1
Cao, S; Ding, C; Wang, R; Xia, M; Zhu, X	1
Guo, C; Guo, M; Hou, Z; Huang, Y; Li, Z; Mou, Y; Wang, X; Wang, Y; Wei, Y; Yan, Z; Zhao, D	1

Reviews

3 review(s) available for fluconazole and warfarin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Drug interactions: Part I. The Annals of pharmacotherapy, 1992, Volume: 26, Issue:5 Topics: Antidepressive Agents, Tricyclic; Caffeine; Cimetidine; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Fluconazole; Fluoxetine; Hexobarbital; Humans; Ketoconazole; Nimodipine; Oxidoreductases; Pharmaceutical Preparations; Rifampin; Stereoisomerism; Warfarin; Zidovudine	1992
Three Serious Drug Interactions that Every Dentist Should Know About. Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995), 2015, Volume: 36, Issue:6 Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Bradycardia; Cytochrome P-450 CYP2C9; Dental Care; Drug Interactions; Epinephrine; Fluconazole; Hemorrhage; Humans; International Normalized Ratio; Lithium; Metronidazole; Propranolol; Warfarin	2015

Trials

5 trial(s) available for fluconazole and warfarin

Article	Year
[Interaction studies with fluconazole, a new triazole antifungal drug]. Wiener medizinische Wochenschrift (1946), 1989, Aug-31, Volume: 139, Issue:15-16 Topics: Adult; Antipyrine; Cimetidine; Clinical Trials as Topic; Contraceptives, Oral; Cyclosporins; Double-Blind Method; Drug Interactions; Female; Fluconazole; Humans; Male; Testosterone; Tolbutamide; Warfarin	1989
Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies. Drug metabolism and disposition: the biological fate of chemicals, 1996, Volume: 24, Issue:4 Topics: Adult; Anticoagulants; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Fluconazole; Half-Life; Humans; Male; Prothrombin Time; Stereoisomerism; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Warfarin	1996
Kiiv, an in vivo parameter for predicting the magnitude of a drug interaction arising from competitive enzyme inhibition. Drug metabolism and disposition: the biological fate of chemicals, 2003, Volume: 31, Issue:8 Topics: Administration, Oral; Adult; Algorithms; Aryl Hydrocarbon Hydroxylases; Binding, Competitive; Cross-Over Studies; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Kinetics; Male; Metabolic Clearance Rate; Prothrombin Time; Stereoisomerism; Time Factors; Warfarin	2003
Reducing warfarin medication interactions: an interrupted time series evaluation. Archives of internal medicine, 2006, May-08, Volume: 166, Issue:9 Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Drug Interactions; Drug Prescriptions; Education, Medical, Continuing; Female; Fluconazole; Health Maintenance Organizations; Humans; Male; Medical Records Systems, Computerized; Metronidazole; Middle Aged; Sulfamethoxazole; Warfarin	2006
Tecarfarin, a novel vitamin K reductase antagonist, is not affected by CYP2C9 and CYP3A4 inhibition following concomitant administration of fluconazole in healthy participants. Journal of clinical pharmacology, 2011, Volume: 51, Issue:4 Topics: Administration, Oral; Adult; Aryl Hydrocarbon Hydroxylases; Benzoates; Coumarins; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Fluconazole; Humans; Male; NAD(P)H Dehydrogenase (Quinone); Warfarin	2011

Other Studies

41 other study(ies) available for fluconazole and warfarin

Article	Year
Prediction of drug solubility from Monte Carlo simulations. Bioorganic & medicinal chemistry letters, 2000, Jun-05, Volume: 10, Issue:11 Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility	2000
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR. European journal of medicinal chemistry, 2011, Volume: 46, Issue:1 Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics	2011
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents. Journal of medicinal chemistry, 2015, Feb-12, Volume: 58, Issue:3 Topics: Amides; Animals; Cell Line; Chagas Disease; Dose-Response Relationship, Drug; Methanol; Mice; Mice, Inbred BALB C; Molecular Structure; Parasitic Sensitivity Tests; Rats; Structure-Activity Relationship; Triazoles; Trypanocidal Agents; Trypanosoma brucei rhodesiense; Trypanosoma cruzi	2015
Drug interactions with fluconazole. The Medical journal of Australia, 1992, Mar-02, Volume: 156, Issue:5 Topics: Cross-Sectional Studies; Cyclosporine; Drug Interactions; Fluconazole; Humans; Phenytoin; Theophylline; Warfarin	1992
Possible potentiation of warfarin by fluconazole. DICP : the annals of pharmacotherapy, 1990, Volume: 24, Issue:12 Topics: Administration, Oral; Aged; Drug Synergism; Female; Fluconazole; Humans; Warfarin	1990
Fluconazole-warfarin interaction. The Annals of pharmacotherapy, 1994, Volume: 28, Issue:9 Topics: Adult; Drug Interactions; Epistaxis; Female; Fluconazole; Gingival Hemorrhage; Humans; Melena; Warfarin	1994
Low-dose fluconazole therapy potentiates the hypoprothrombinemic response of warfarin sodium. Archives of internal medicine, 1993, Jan-11, Volume: 153, Issue:1 Topics: Aged; Aged, 80 and over; Drug Synergism; Fluconazole; Humans; Male; Middle Aged; Prothrombin; Prothrombin Time; Warfarin	1993
Case report: potentiation of warfarin by fluconazole. The American journal of the medical sciences, 1993, Volume: 305, Issue:3 Topics: Aged; Drug Synergism; Female; Fluconazole; Gastrointestinal Hemorrhage; Humans; Warfarin	1993
Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19. Drug metabolism and disposition: the biological fate of chemicals, 1996, Volume: 24, Issue:5 Topics: Aryl Hydrocarbon Hydroxylases; Biomarkers; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fluconazole; Humans; Hydroxylation; Kinetics; Mephenytoin; Microsomes, Liver; Mixed Function Oxygenases; Monoamine Oxidase Inhibitors; Theophylline; Tranylcypromine; Warfarin	1996
Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies. Drug metabolism and disposition: the biological fate of chemicals, 1996, Volume: 24, Issue:4 Topics: Anticoagulants; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Fluconazole; Humans; In Vitro Techniques; Microsomes, Liver; Mixed Function Oxygenases; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Warfarin	1996
Warfarin-fluconazole. III. A rational approach to management of a metabolically based drug interaction. Drug metabolism and disposition: the biological fate of chemicals, 1996, Volume: 24, Issue:4 Topics: Anticoagulants; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Fluconazole; Humans; Hypoglycemic Agents; Models, Biological; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Tolbutamide; Warfarin	1996
Treating oral candidiasis: potentially fatal. British dental journal, 1997, Aug-09, Volume: 183, Issue:3 Topics: Anti-Bacterial Agents; Anticoagulants; Antifungal Agents; Candidiasis, Oral; Drug Interactions; Erythromycin; Fluconazole; Humans; Warfarin	1997
Intraocular hemorrhages due to warfarin fluconazole drug interaction in a patient with presumed Candida endophthalmitis. Archives of ophthalmology (Chicago, Ill. : 1960), 2002, Volume: 120, Issue:1 Topics: Adult; Anticoagulants; Antifungal Agents; Candidiasis; Choroid Hemorrhage; Drug Interactions; Endophthalmitis; Eye Hemorrhage; Eye Infections, Fungal; Fluconazole; Humans; Male; Retinal Hemorrhage; Ultrasonography; Vitreous Hemorrhage; Warfarin	2002
Spinal epidural haematoma as a result of warfarin/fluconazole drug interaction. European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 2002, Volume: 9, Issue:2 Topics: Adult; Aged; Anticoagulants; Antifungal Agents; Drug Interactions; Female; Fluconazole; Hematoma, Epidural, Cranial; Humans; Male; Spinal Cord Diseases; Warfarin	2002
Single-dose fluconazole for vulvovaginal candidiasis: impact on prothrombin time in women taking warfarin. Obstetrics and gynecology, 2006, Volume: 107, Issue:2 Pt 1 Topics: Anticoagulants; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Middle Aged; Prothrombin Time; Time Factors; Warfarin	2006
Fluconazole-induced intoxication with phenytoin in a patient with ultra-high activity of CYP2C9. European journal of clinical pharmacology, 2010, Volume: 66, Issue:8 Topics: Alleles; Angiotensin II Type 1 Receptor Blockers; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Ataxia; Behcet Syndrome; Case-Control Studies; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Fatigue; Female; Fluconazole; Humans; Losartan; Middle Aged; Pharmaceutical Preparations; Phenotype; Phenytoin; Polymorphism, Genetic; Speech Intelligibility; Warfarin	2010
[Synthesis and antimicrobial evaluation of coumarin-based benzotriazoles and their synergistic effects with chloromycin and fluconazole]. Yao xue xue bao = Acta pharmaceutica Sinica, 2011, Volume: 46, Issue:7 Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Chloramphenicol; Coumarins; Drug Synergism; Fluconazole; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Methicillin-Resistant Staphylococcus aureus; Staphylococcus aureus; Triazoles	2011
A new and efficient method for the synthesis of novel 3-acetyl coumarins oxadiazoles derivatives with expected biological activity. Molecules (Basel, Switzerland), 2014, Jan-14, Volume: 19, Issue:1 Topics: Anti-Bacterial Agents; Antifungal Agents; Bacillus subtilis; Benzothiazoles; Biphenyl Compounds; Coumarins; Escherichia coli; Fluconazole; Free Radical Scavengers; Free Radicals; Fungi; Microbial Sensitivity Tests; Molecular Conformation; Nuclear Magnetic Resonance, Biomolecular; Oxadiazoles; Picrates; Salmonella typhi; Shigella flexneri; Staphylococcus aureus; Sulfonic Acids	2014
Comparison of the effects of azole antifungal agents on the anticoagulant activity of warfarin. Biological & pharmaceutical bulletin, 2014, Volume: 37, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antifungal Agents; Drug Interactions; Drug Resistance; Female; Fluconazole; Humans; International Normalized Ratio; Itraconazole; Male; Metabolism, Inborn Errors; Middle Aged; Retrospective Studies; Voriconazole; Warfarin	2014
In silico evaluation of warfarin-bucolome therapy. Biopharmaceutics & drug disposition, 2016, Volume: 37, Issue:4 Topics: Anticoagulants; Barbiturates; Computer Simulation; Cytochrome P-450 CYP2C9 Inhibitors; Drug Therapy, Combination; Fluconazole; Humans; Models, Biological; Warfarin	2016
Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation. European journal of medical genetics, 2017, Volume: 60, Issue:1 Topics: Abnormalities, Drug-Induced; Angiotensin-Converting Enzyme Inhibitors; Animals; Female; Fetal Diseases; Fetus; Fluconazole; Humans; Isoxazoles; Leflunomide; Mutation; Mycophenolic Acid; Phenotype; Pregnancy; Teratogenesis; Teratogens; Thalidomide; Warfarin	2017
Potent Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8 Topics: Antifungal Agents; Candida albicans; Candidiasis; Coumarins; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fluconazole; Gene Expression Regulation, Fungal; Microbial Sensitivity Tests; Oxidative Stress; Reactive Oxygen Species	2017
Antifungal activity of osthol in vitro and enhancement in vivo through Eudragit S100 nanocarriers. Virulence, 2018, 01-01, Volume: 9, Issue:1 Topics: Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis; Coumarins; Disease Models, Animal; Drug Carriers; Drug Synergism; Fluconazole; Mice; Plasma; Polymethacrylic Acids; Treatment Outcome	2018
Population Impact of Drug Interactions with Warfarin: A Real-World Data Approach. Thrombosis and haemostasis, 2018, Volume: 118, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anticoagulants; Carbamazepine; Databases, Factual; Drug Interactions; Female; Fluconazole; Follow-Up Studies; Humans; International Normalized Ratio; Male; Miconazole; Middle Aged; Nystatin; Primary Health Care; Retrospective Studies; United Kingdom; Warfarin; Young Adult	2018
Bleeding interaction between fluconazole and warfarin. Lancet (London, England), 2018, 09-29, Volume: 392, Issue:10153 Topics: Aged; Anticoagulants; Antifungal Agents; Drug Interactions; Female; Fluconazole; Hematoma; Humans; Pharyngeal Diseases; Warfarin	2018
A stitch in time saves nine. Lancet (London, England), 2019, 05-11, Volume: 393, Issue:10184 Topics: Fluconazole; Hemorrhage; Humans; Warfarin	2019
Antimycotic Treatment of Oral Candidiasis in Warfarin Users. The American journal of medicine, 2021, Volume: 134, Issue:5 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antifungal Agents; Candidiasis, Oral; Drug Interactions; Female; Fluconazole; Gels; Humans; International Normalized Ratio; Male; Miconazole; Solutions; Warfarin	2021
Fungal endocarditis with heart valve replacement and atrial fibrillation posing a treatment challenge: A case report. Medicine, 2020, Nov-25, Volume: 99, Issue:48 Topics: Antifungal Agents; Atrial Fibrillation; Candida parapsilosis; Candidiasis; Caspofungin; Combined Modality Therapy; Diagnosis, Differential; Endocarditis, Non-Infective; Female; Fluconazole; Hemiplegia; Humans; Infarction, Middle Cerebral Artery; Middle Aged; Mitral Valve; Prosthesis-Related Infections; Warfarin	2020
Developing Novel Coumarin-Containing Azoles Antifungal Agents by the Scaffold Merging Strategy for Treating Azole-Resistant Candidiasis. Journal of medicinal chemistry, 2023, 09-28, Volume: 66, Issue:18 Topics: Antifungal Agents; Azoles; Candidiasis; Coumarins; Fluconazole; Humans	2023